Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael R. Migden
Correction To: Long-Term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma: Final Update of the Pivotal ERIVANCE BCC Study
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
Dermatology and Therapy
Dermatology
Lack of Response to Vismodegib in a Patient With Advanced Basal Cell Carcinoma: A Case Report
Journal of Clinical & Experimental Oncology
Vismodegib and Orbital Excision for Treating Locally Advanced Basal Cell Carcinoma
International Medical Case Reports Journal
Medicine
035 Experiences With Smo Antagonist Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
233 Cohort Study of High Frequency Basal Cell Carcinoma (BCC) Patients in Denmark
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
533 Pembrolizumab With or Without Vismodegib for Advanced Basal Cell Carcinoma: An Investigator-Initiated, Proof-Of-Concept Study
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Vismodegib for Periocular and Orbital Basal Cell Carcinoma
JAMA Ophthalmology
Ophthalmology
Predictors of Long-Term Response With Pazopanib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Vismodegib for Giant, Locally Advanced, Basal Cell Carcinoma and Its Complex Position in Clinical Practice
JAAD Case Reports
Dermatology